[LEC] Liver Enzymes Flashcards
5 MAJOR LIVER ENZYMES
AST
ALT
GGT
ALP
5’ NTP
RECOMMENDED NAME OF AST
ASPARTATE AMINO TRANSFERASE
ENZYME CLASS OF AST
TRANSFERASE
EC CODE OF AST
2.6.1.1
SYSTEMATIC NAME OF AST
L-ASPARTATE-2-OXOGLUTARATE AMINOTRANSFERASE
FORMER NAME OF AST
SGOT
SERUM GLUTAMIC OXALOACETIC TRANSAMINASE
COENZYME OF AST
PYRIDOXAL PHOSPHATE
CHEMICAL REACTION OF AST
ASPARTATE + ALPHA-KTOGLUTARATE <—AST—> OXALOACETATE + GLUTAMATE
WHICH ENZYME HAS A SHORTER HALF LIFE
AST OR ALT
AST
IN AST, ALPHA KETO ACIDS ARE OXIDIZED BY WHAT REACTION
TCA CYCLE
TRICARBOXYLIC ACID CYCLE
WHAT DOES THE TCA CYCLE PRODUCE
ENERGY
MAJOR TISSUE SOURCES OF AST
CARDIAC TISSUE
LIVER
SKELETAL MUSCLE
MINOR TISSUE SOURCES OF AST
KIDNEY
PANCREAS
ERYTHROCYTES
ISOENZYME FRACTIONS OF AST
CYTOPLASM — Predominant form; found in healthy sera
MITOCHONDRIA — Abnormal; found in cellular necrosis
IS AST ISOENZYME ANALYSIS ROUTINELY DONE
NO
CLINICAL SIGNIFICANCES OF AST
HEPATOCELLULAR DISORDERS
SKELETAL MUSCLE INVOLVEMENT
ANGINA PECTORIS
AST IS USED TO FOLLOW THE COURSE OF WHAT CLINICAL CONDITION
MYOCARDIAL INFARCTION
— But is not used to diagnose
PREDOMINANT AST ISOENZYME FORM
CYTOPLASMIC AST
ISOENZYME OF AST THAT APPEARS WHEN CELLULAR NECROSIS OCCURS
MITOCHONDRIAL AST
PATIENT IS DIAGNOSED WITH CHRONIC ALCOHOLISM,
WHAT AST ISOENZYME IS INCREASED
MITOCHONDRIAL AST
CYTOPLASMIC AST IS FOUND IN PATIENT X’S SERUM SAMPLE.
IS THE PATIENT SUFFERING FROM ANY CLINICAL CONDITION
NO
CYTOPLASMIC AST IS FOUND IN HEALTHY HUMAN SERA
EFFECT OF ALCOHOL ON HEPATOCYTES
ALCOHOL DESTROYS HEPATOCYTES
MITOCHONDRIAL AST INCREASES
THE TWO MAIN ENZYMES USED TO MONITOR HEPATOCELLULAR DISORDERS
AST
ALT
TRUE OR FALSE
AST IS USED IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION
FALSE
WHAT ARE THE TIME ACTIVITY OF AST IN ANGINA PECTORIS
RISE — 6 TO 8 HRS AFTER ONSET
PEAK — 24 HRS
RETURNS — WITHIN 3-5 DAYS (OR WITHIN 5 DAYS)
HIGHEST ELEVATION OF AST
5X ULN
CLINICAL CONDITIONS OF AST WHEN ELEVATIONS REACH 5 OR MORE X ULN
ACUTE HEPATOCELLULAR DISORDERS
MYOCARDIAL INFARCTION
CIRCULATORY COLLAPSE (SHOCK)
ACUTE PANCREATITIS
INFECTIOUS MONONUCLEOSIS
KEY TAKEAWAYS:
ACUTE, SUDDEN
CLINICAL CONDITIONS OF AST WHEN ELEVATIONS ARE MODERATE
BILIARY TRACT OBSTRUCTION
CARDIAC ARRYTHMIAS
CONGESTIVE FAILURE
METASTATIC OR PRIMARY TUMOR IN LIVER
MUSCULAR DYSTROPHY
KEY TAKEAWAYS: OBSTRUCTION, FAILURE TO FUNCTION
CLINICAL CONDITIONS OF AST WHEN ELEVATION IS SLIGHT
PERICARDITIS
CIRRHOSIS
PULMONARY INFARCTION
DELIRIUM TREMENS
CEREBROVASCULAR ACCIDENT
HEPATOTOXIC DRUG INTAKE
KEY TAKEAWAYS: INFLAMMATION, INJURY, DRUGS
WHAT ENZYME IS USED TO MONITOR HEPATOTOXIC DRUGS
AST
LIMIT AT WHICH THE PHYSICIAN STOPS THE PATIENT’S THERAPY WITH HEPATOTOXIC DRUGS
UP TO 3X ULN
[RATIO SUMMARY]
HALF LIFE OF AST AND ALT
AST < ALT
[RATIO SUMMARY]
LEVELS OF AST AND ALT IN LIVER DISEASES
AST < ALT
[RATIO SUMMARY]
DE RITIS RATIO
ALT:AST > 1 — ACUTE HEPATITIS
AST > ALT — ALCOHOLIC HEPATITIS
[RATIO SUMMARY]
AST AND ALT LEVELS IN HEPATOCELLULAR CIRRHOSIS
AST > ALT
[RATIO SUMMARY]
AST AND ALT LEVELS IN LIVER NEOPLASIA
AST > ALT
WHY IS AST HIGHER THAN ALT IN CASES OF HEPATOCELLULAR CIRRHOSIS AND LIVER NEOPLASIA
BECAUSE HEPATOCYTES ARE SEVERELY DAMAGED
HEPATOCYTES HAVE HIGH AST ACTIVITY
[RATIO SUMMARY]
AST AND ALT LEVELS IN LIVER SPECIFICITY
AST < ALT
ENZYME CLASSIFICATION OF ALT
TRANSFERASE
EC CODE OF ALT
2.6.1.2
SYSTEMATIC NAME OF ALT
L-ALANINE-2-OXIDOGLUTARATE AMINOTRANSFERASE
RECOMMENDED NAME OF ALT
ALANINE AMINOTRANSFERASE
COENZYME OF ALT
PYRIDOXAL PHOSPHATE
HALF LIFE OF AST
16 HRS
HALF LIFE OF ALT
24 HRS
PYRIDOXAL PHOSPHATE IS THE COENZYME OF WHICH LIVER ENZYMES
AST AND ALT
MAJOR TISSUE SOURCE OF ALT
LIVER (More specific than AST)
KIDNEY
MINOR TISSUE SOURCES OF ALT
HEART
SKELETAL MUSCLE
IN WHAT CLINICAL CONDITION IS AST MORE ELEVATED THAN ALT AND WHY
ACUTE HEPATOCELLULAR CIRRHOSIS
LIVER NEOPLASIA
HEPATOCYTES ARE SEVERELY DAMAGED
HEPATOCYTES HAVE HIGHER AST ACTIVITY
ARE ALT ELEVATIONS OBSERVED IN PATIENTS WHO ARE NON ALCOHOLIC AND ASYMPTOMATIC
YES
WHAT SCREENING PROCEDURE IS ALT USED IN
SCREENING FOR BLOOD DONORS
SCREENING POST TRANSFUSION (FOR POST TRANSFUSION HEPATITIS)
MILD ALT ELEVATIONS ARE FOUND IN WHAT CLINICAL CONDITIONS
HEPATITIS C INFECTIONS
WHAT ENZYME IS MORE SPECIFIC FOR THE LIVER
ALT
CHEMICAL REACTION OF ALT
ALANINE + A-KETOGLUTARATE <—ALT—> PYRUVATE + GLUTAMATE
[RATIO SUMMARY]
ENZYME ACTIVITY IN HEPATOCYTES
AST > ALT
ENZYME CLASSIFICATION OF ALP
HYDROLASE
EC CODE OF ALP
3.1.3.1
RECOMMENDED NAME OF ALP
ALKALINE PHOSPHATE
SYSTEMATIC NAME OF ALP
ALKALINE ORTHOPHOSPHERIC MONOESTER PHOSPHOHYDROLASE
OPTIMUM PH AT WHICH ALP FUNCTIONS
pH 9-10
MAJOR TISSUE SOURCES OF ALP
CANALICULAR MEMBRANE OF THE LIVER
OSTEOBLASTS IN THE BONE
MINOR TISSUE SOURCES OF ALP
MUCOSA OF THE SMALL INTESTINE
PROXIMAL CONVOLUTED TUBE OF THE KIDNEYS
PLACENTA
ISOFORMS OF ALP BASED ON GENETIC LOCUS
CHR 1 — KIDNEY, LIVER, BONE
CHR 2 — PLACENTA, INTESTINE
WHAT ALP TISSUE SOURCE IS CODED FOR BY CHROMOSOME 1
KIDNEY
LIVER
BONE
WHAT ALP TISSUE SOURCE IS CODED FOR BY CHROMOSOME 2
PLACENTA
INTESTINES
WHAT ARE THE NORMAL ISOENZYMES OF ALP
INTESTINAL
PLACENTAL
BONE AND LIVER
MOST PREDOMINANT ISOENZYME FRACTION OF ALP
BONE AND LIVER ALP
WHAT ARE THE ABNORMAL ISOENZYME FRACTIONS OF ALP
REGAN
NAGAO
KASHARA
WHAT ISOENZYME FRACTION RESULTS WHEN THERE IS AN ECTOPIC PRODUCTION OF ALP
REGAN
IN WHAT CONDITIONS IS THE REGAN FRACTION FOUND IN
LUNG, BREAST, COLON CANCERS
OVARIAN AND GYNECOLOGICAL CANCERS (HIGH INCIDENCE)
IN WHAT CONDITIONS DOES THE REGAN ISOENZYME FRACTION HAVE THE HIGHEST INCIDENCE IN
OVARIAN AND GYNECOLOGICAL CANCERS
MOST HEAT STABLE ALP ISOENZYME FORM
REGAN
WHAT HEAT CONDITION CAN THE REGAN FRACTION RESIST
UP TO 60C FOR 30 MINS
WHAT ISOENZYME FORM IS A VARIANT OF THE REGAN FORM
NAGAO
IN WHAT CONDITION IS THE NAGAO FORM FOUND IN
PLEURAL CANCER
(WITH NAGAO)
IN WHAT CONDITIONS IS THE KASAHARA FORM FOUND ELEVATED IN
HEPATOMA
GIT TUMORS
METHODS OF SEPARATING THE ALP ISOENZYMES
ELECTROPHORESIS
HEAT DENATURATION OR HEAT STABILITY TEST
CHEMICAL INHIBITION
ELECTROPHORETIC ABILITY OF ALP FRACTIONS
(SLOWEST TO FASTEST TOWARDS THE ANODE)
INTESTINAL > PLACENTAL > BONE > MAJOR LIVER > A1
IPBMA
SUB FRACTIONS OF THE ALP LIVER ISOENZYME
MAJOR LIVER
FAST/A1
RESULTS OF HEAT DENATURATION OF ALP FRACTIONS
(LEAST TO MOST HEAT STABLE)
BONE > LIVER > INTESTINAL > PLACENTAL
BLIP
HEAT CONDITIONS USED IN THE HEAT DENATURATION METHOD OF ALP
SERUM IS TREATED AT 56C FOR 10-15 MINS
MOST HEAT STABLE NORMAL ISOENZYME OF ALP
PLACENTA
MOST HEAT STABLE ALP ISOENZYME (OUT OF ALL OF THEM)
NAGAO
ALP FRACTIONS INHIBITED BY L-PHENYLALANINE
PLACENTAL
INTESTINAL
REGAN
NAGAO
(PIRN)
ALP FRACTIONS INHIBITED BY LEVAMISOL
LIVER
BONE
ALP FRACTIONS INHIBITED BY L-HOMOARGININE
LIVER AND BONE
WHAT CHEMICALS INHIBIT THE BONE AND LIVER ALPs
LEVAMISOL
L-HOMOARGININE
ALP FRACTIONS INHIBITED BY 2M UREA
BONE
ALP FRACTIONS INHIBITED BY L-LEUCINE
NAGAO
ALP FRACTIONS INHIBITED BY 20% ETHANOL
DENATURES LIVER ALP MORE RAPIDLY THAN BONE ALP
TRUE OR FALSE
2M UREA DENATURES BONE ALP MORE RAPIDLY THAN LIVER ALP
FALSE
20% ETHANOL DENATURES LIVER ALP MORE THAN BONE ALP
CHEMICAL INHIBITORS OF ALP
L-PHENYLALANINE — Placental, intestinal, regan, nagao
LEVAMISOL — Bone and liver
L-HOMOARGININE — Bone and liver
2M UREA — Bone
L-LEUCINE — Nagao
20% ETHANOL — Denatures Liver ALP > Bone ALP
PRONOUNCEED ELEVATION OF ALP
5 OR MORE X ULN
MODERATE ELEVATION OF ALP
3-5X ULN
SLIGHT ELEVATION OF ALP
UP TO 3X ULN
CLINICAL CONDITIONS IN PRONOUNCED ELEVATION OF ALP
(5X OR MORE ULN)
BILIARY DUCT OBSTRUCTION
BILIARY CIRRHOSIS
PAGET’S DISEASE — OSTEOTITIS DEFORMANS
HYPERPARATHYROIDISM
OSTEOGENIC CARCINOMA
PAGET’S DISEASE IS ALSO REFERRED TO AS
OSTEOTITIS DEFORMANS
CLINICAL CONDITIONS IN MODERATE ELEVATION OF ALP
(3-5X ULN)
GRANULOMATOUS OR INFLITRATIVE DISEASES OF LIVER
INFECTIOUS MONONUCLEOSIS
METASTATIC TUMORS IN BONES
METABOLIC BONE DISEASES (RICKETS AND OSTEOMALACIA)
CLINICAL CONDITIONS IN SLIGHT ELEVATIONS OF ALP
(UP TO 3X ULN)
VIRAL HEPATITIS
CIRRHOSIS
HEALING FRACTURES
PREGNANCY (3RD TRIMESTER UNTIL LABOR)
NORMAL GROWTH OF CHILDREN
CLINICAL CONDITIONS IN DECREASED ALP LEVELS
HYPOPHOSPHATASIA
CLINICAL CONDITIONS IN THE B1X FORM (BONE ALP ISOFORM)
DIALYSIS PATIENT SERUM (CHRONIC KIDNEY DISEASE)
LOW BONE MINERAL DISEASE (BMD)
BMD OF THE HIP
SINCE REGAN IS A VARIANT OF NAGAO, CAN IT ALSO BE INHIBITED BY L-LEUCINE?
NO
IN THE HEAT DENATURATION OF ALP, IF >20% ACTIVITY REMAINS, THE ELEVATION IN ALP IS DUE TO WHAT ISOENZYME
LIVER ALP
IN THE HEAT DENATURATION OF ALP, IF <20% ACTIVITY REMAINS, THE ELEVATION IN ALP IS DUE TO WHAT ISOENZYME
BONE ALP
WHY IS THERE NO ALP INCREASE IN INHERITED HYPOPHOSPHATASIA
BONE ALP IS ABSENT
THERE IS IMPAIRED MINERALIZATION AND CALCIFICATION
Recall: Osteoblasts are one of the main sources of ALP
WHAT IS THE RATIONALE OF ALP BEING INCREASED IN CHILDREN
DUE TO THEIR EPIPHYSEAL PLATES BEING BROKEN DOWN
WITHIN HOW MANY DAYS DOES ALP RETURN TO NORMAL LEVELS IN A PREGNANT PERSON
6 DAYS AFTER LABOR
ENZYME CLASSIFICATION OF GGT
TRANSFERASES
EC CODE OF GGT
2.3.2.2
RECOMMENDED NAME OF GGT
GAMMA GLUTAMYL TRASNFERASE
SYSTEMATIC NAME OF GGT
5-GLUTAMYL PEPTODE AMINO ACID-5-GLUTAMYLTRANSFERASE
CHEMICAL REACTION OF GGT
GLUTATHIONE + AMINO ACID <—> GLUTAMYL — PEPTIDE + L-CYSETINGLYCINE
FUNCTIONS OF GGT
PEPTIDE AND PROTEIN SYNTHESIS
REGULATION OF TISSUE GLUTATHIONE LEVELS
TRANSPORT OF AMINO ACIDS ACROSS CELL MEMBRANES
WHAT ENZYME IS RESPONSIBLE FOR THE REGULATION OF TISSUE GLUTATHIONE LEVELS
GGT
MAJOR TISSUE SOURCES OF GGT
KIDNEY
MINOR (OTHER) TISSUE SOURCES OF GGT
LIVER — MOST PREDOMINANT IN SERUM
PROSTATE
PANCREAS — LEAST
IN WHAT SPECIFIC PART OF THE LIVER IS GGT PRESENT IN
EPITHELIAL LINING OF THE BILIARY DUCTULES
CLINICAL CONDITIONS IN WHICH GGT IS ELEVATED
HEPATOBILIARY DISORDERS
ENZYME INDUCING DRUGS
ALCOHOLIC HEPATITIS
ACUTE PANCREATITIS
PROSTATIC DISORDERS
DIABETES MELLITUS
MYOCARDIAL INFARCTION — IF INCREASED AT THE 4TH DAY
WHAT ENZYMES INCREASE THE MOST DUE TO BILIARY DESTRUCTION
ALP
GGT
AMOUNT OF GGT INCREASE IN HEPATOBILIARY DISORDERS
5-30X ULN
GGT ENZYME-INDUCTING DRUGS
WARFARIN
PHENOBARBITAL
PHENYTOIN
MOST SENSITIVE MARKER OF ALCOHOLISM
GGT
RATIONALE OF GGT INCREASING IN DIABETES MELLITUS
GGT CONCENTRATIONS ARE FOUND IN THE PANCREAS
THE PANCREAS CONTAINS BETA CELLS
BETA CELLS ARE DESTROYED DUE TO TISSUE DAMAGE
THERE WILL BE A RELEASE OF GGT
WHAT LEVEL OF GGT IS EXPECTED IN MYOCARDIAL INFARCTION
NORMAL
WHEN IS GGT INCREASED IN MYOCARDIAL INFARCTION AND WHAT IS THE RESULTING CONDITION
INCREASED BEYOND THE 4TH DAY
LIVER DAMAGE SECONDARY TO CARDIAC INSUFFICIENCY
[ELEVATION SUMMARY]
GGT AND ALP IN SKELETAL DISORDERS
GGT — NORMAL
ALP — INCREASED
[ELEVATION SUMMARY]
GGT AND ALP IN PREGNANCY
GGT — NORMAL
ALP — INCREASED
[ELEVATION SUMMARY]
GGT AND ALP IN HEPATOBILIARY DISEASE
GGT — INCREASED
ALP — INCREASED
[ELEVATION SUMMARY]
GGT AND ALP IN BONE FRACTURES
GGT — NORMAL
ALP — INCREASED
IN WHAT CLINICAL CONDITION IS GGT NORMAL WHILE ALP IS INCREASED
SKELETAL DISORDERS
PREGNANCY
BONE FRACTURES
IN WHAT CLINICAL CONDITION ARE BOTH GGT AND ALP INCREASED
HEPATOBILIARY DISEASES
ENZYME CLASSIFICATION OF NTP
HYDROLASE
EC CODE OF NTP
3.1.3.5
SYSTEMATIC NAME OF NTP
5’-RIBONUCLEOTIDE PHOPSPHOHYDROLASE
RECOMMENDED NAME OF NTP
5’ NUCLEOTIDASE
3-5X ULN ELEVATION OF NTP IS SEEN IN WHAT CLINICAL CONDITION
HEPATOBILIARY DISEASES
MODERATE ELEVATION OF NTP IS SEEN IN WHAT CLINICAL CONDITION
INFECTIOUS HEPATITIS
TRUE OR FALSE
NTP INCREASES WHETHER THE CONDITION IS OF INTRA OR EXTRAHEPATOBILIARY ORIGIN
TRUE
IN WHAT CONDITION DOES ONLY ALP INCREASE
BONE DISORDERS
IN WHAT CONDITION DOES ALP AND NTP INCREASE
LIVER DISEASES
PREGNANCIES ***
ENZYME CLASSIFICATION OF GLD
OXIDOREDUCTASE
EC CODE OF GLD
1.4.1.3
RECOMMENDED NAME OF GLD
GLUTAMATE DEHYDROGENASE
SYSTEMATIC NAME OF GLD
L-GLUTAMATE:NAD(P) OXIDOREDUCTASE, DEAMINASE
MAJOR TISSUE SOURCE OF GLD
LIVER
MODERATE SOURCES OF GLD
HEART MUSCLE
KIDNEYS
MINOR (LEAST) TISSUE SOURCE OF GLD
BRAIN
SKELETAL MUSCLE
LEUKOCYTES
GLD ELEVATION OF 4-5X ULN RESULTS IN WHAT CONDITION
CHRONIC HEPATITIS
GLD ELEVATION OF 2X ULN RESULTS IN WHAT CONDITION
LIVER CIRRHOSIS
GLD IS ELEVATED DUE TO WHAT DRUG
HALOTHANE
— AN INHALANT FOR GENERAL ANESTHESIA
WHAT ENZYMES INCREASE IN SEVERE LIVER CELL DAMAGE
AST
GGT
ENZYME CLASSIFICATION OF GST
TRANSFERASES
RECOMMENDED NAME OF GST
GLUTATHIONE-S-TRANSFERASE
EC CODE OF GST
2.5.1.18
SYSTEMATIC NAME OF GST
GLUTATHIONE TRANSFERASE
CLINICAL SIGNIFICANCES OF GST
ALPHA GST IS DISTRIBUTED IN THE LIVER ACINES
HEPATOCELLULAR DAMAGE
LIVER TRANSPLANTATION — CHECK FOR REJECTION
ENZYME CLASSIFICATION OF CHE
HYDROLASES
EC CODE OF CHE
3.1.1.7
RECOMMENDED NAME OF CHE
CHOLINESTERASE
SYSTEMATIC NAME OF CHE
ACETYLCHOLINE ACETYLHYDROLASE
EC CODE OF PSEUDO CHE
3.1.1.8
OTHER NAMES OF CHE
CHOLINESTERASE 1
TRUE CHOLINESTERASE
RED CELL CHOLINESTERASE
TISSUE SOURCES OF CHE
RBCS
LUNGS
SPLEEN
NERVE ENDINGS
GRAY MATTER OF THE BRAIN
CLINICAL SIGNIFICANCE S OF CHE
INHIBITION OF NEUROTRANSMISSION
DETECTION OF NEURAL TUBE DEFECTS
WHAT ENZYME IS USED TO INHIBIT NEUROTRANSMISSION
CHE
WHAT IS THE CLINICAL CONDITION IN WHICH NEURAL TUBE DEFECTS CAUSE PROBLEMS WITH THE SPINE
SPINA BIFIDA
WHAT IS THE CLINICAL CONDITION IN WHICH NEURAL TUBE DEFECTS CAUSE PROBLEMS WITH THE BRAIN
ANENCEPHALY
SAMPLE USED TO TEST FOR NEURAL TUBE DEFECTS
AMNIOTIC FLUID
OTHER NAMES OF PSEUDO CHE
PSEUDOCHOLINESTERASE
SERUM CHOLINESTERASE
BUTYRYLCHOLINESTERASE
CHOLINESTERASE
TISSUE SOURCES OF PSEUDO CHE
LIVER
PANCREAS
HEART
WHITE MATTER OF THE BRAIN
SERUM
WHAT IS THE ONZLY ENZYME THAT DECREASES IN THE PRESENCE OF A DISORDER
PSEUDO CHE
ENZYME THAT IS A SENSITIVE INDICATOR OF LIVER SYNTHETIC CAPACTIY
PSEUDOCHOLINESTERASE
ENZYME LEVELS OF PSEUDO CHE IN THE PRESENCE OF A DISORDER
DECREASED
A 30-50% DECREASE IN PSEUDO CHE IS INDICATIVE OF WHAT CLINICAL CONDITION
ACUTE AND CHRONIC HEPATITIS
A 50-70% DECREASE IN PSEUDO CHE IS INDICATIVE OF WHAT CLINICAL CONDITION
METASTATIC CARCINOMA
CIRRHOSIS
CLINICAL CONDITION RELATED TO PSEUDOCHOLINESTERASE AND EXPOSURE TO INSECTICIDES
INSECTICIDE POISONING
ORGANOPHOSPHATE POISONING
CHEMICAL INVOLVED IN INSECTICIDE POISONING
ORGANOPHOSPHATE POISONING
INCREASE OF CHE IN PATIENTS LEAD TO WHT CLINICAL CONDITION
PROLONGED MUSCLE PARALYSIS
WHAT IS KNOWN AS THE KISSING DISEASE
INFECTIOUS MONONUCLEOSIS
HALLUCINATIONS DUE TO ALCOHOL WITHDRAWAL
DELIRIUM TREMENS
ENZYME USED TO STUDY LOW BONE MINERAL DISEASE
ALP
B1X